BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL
734 results:

  • 1. ScRNA-seq reveals novel immune-suppressive T cells and investigates CMV-TCR-T cells cytotoxicity against GBM.
    Long X; Zhang Z; Li Y; Deng K; Gao W; Huang M; Wang X; Lin X; She X; Zhao Y; Zhang M; Huang C; Wang S; Du Y; Du P; Chen S; Liu Q; Wu M
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38688579
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung cancer: A Meta-Analysis.
    Chi C; Wang C; Dong L; Li X; Xu L
    J Coll Physicians Surg Pak; 2024 Apr; 34(4):461-467. PubMed ID: 38576291
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma.
    Nguyen TT; Torrini C; Shang E; Shu C; Mun JY; Gao Q; Humala N; Akman HO; Zhang G; Westhoff MA; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38483541
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. White and Gray Matter Changes are Associated With Neurocognitive Decline in HIV Infection.
    Chien A; Wu T; Lau CY; Pandya D; Wiebold A; Agan B; Snow J; Smith B; Nath A; Nair G;
    Ann Neurol; 2024 May; 95(5):941-950. PubMed ID: 38362961
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.
    Mirian C; Thastrup M; Mathiasen R; Schmiegelow K; Olsen JV; Østergaard O
    Fluids Barriers CNS; 2024 Feb; 21(1):14. PubMed ID: 38350915
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
    Obrecht-Sturm D; Pfaff E; Mynarek M; Bison B; Rodehüser M; Becker M; Kietz S; Pfister SM; Jones DT; Sturm D; von Deimling A; Sahm F; Kortmann RD; Schwarz R; Pietsch T; Fleischhack G; Rutkowski S
    J Neurooncol; 2024 Jan; 166(2):359-368. PubMed ID: 38253790
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. All cause and cause specific mortality in obsessive-compulsive disorder: nationwide matched cohort and sibling cohort study.
    Fernández de la Cruz L; Isomura K; Lichtenstein P; Larsson H; Kuja-Halkola R; Chang Z; D'Onofrio BM; Brikell I; Rück C; Sidorchuk A; Mataix-Cols D
    BMJ; 2024 Jan; 384():e077564. PubMed ID: 38233033
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A longitudinal evaluation of smell and taste function in children with cancer during and after treatment with chemotherapy.
    van den Brink M; Havermans RC; Fiocco M; Tissing WJE
    Appetite; 2024 Feb; 193():107174. PubMed ID: 38128763
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Single-cell RNA sequencing reveals diverse B cell phenotypes in patients with anti-NMDAR encephalitis.
    Li S; Hu X; Wang M; Yu L; Zhang Q; Xiao J; Hong Z; Zhou D; Li J
    Psychiatry Clin Neurosci; 2024 Mar; 78(3):197-208. PubMed ID: 38063052
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast cancer Metastasis Inhibition.
    Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F
    ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
    Shin JE; Kim SH; Kong M; Kim HR; Yoon S; Kee KM; Kim JA; Kim DH; Park SY; Park JH; Kim H; No KT; Lee HW; Gee HY; Hong S; Guan KL; Roe JS; Lee H; Kim DW; Park HW
    Mol Cancer; 2023 Nov; 22(1):177. PubMed ID: 37932786
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity.
    Villanueva G; Lowe J; Tentoni N; Taluja A; Villarroel M; Narváez CE; León SA; Valencia Libreros DL; Gonzalez Suárez N; Mikkelsen TS; Howard SC
    Pediatr Hematol Oncol; 2024; 41(2):135-149. PubMed ID: 37865916
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group.
    Mallon B; Kaboré R; Couitchere L; Akonde FB; Narison MLR; Budiongo A; Dackono TA; Pondy A; Diedhiou F; Patte C; Steliarova-Foucher E; Clavel J
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30664. PubMed ID: 37732944
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review.
    Dalmage M; LoPresti MA; Sarkar P; Ranganathan S; Abdelmageed S; Pagadala M; Shlobin NA; Lam S; DeCuypere M
    J Neurosurg Pediatr; 2023 Dec; 32(6):665-672. PubMed ID: 37724839
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
    Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
    Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation.
    Kitko CL; Bollard CM; Cairo MS; Chewning J; Fry TJ; Pulsipher MA; Shenoy S; Wall DA; Levine JE
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30577. PubMed ID: 37480158
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Transcription factor abnormalities in B-ALL leukemogenesis and treatment.
    Yin H; Wang J; Tan Y; Jiang M; Zhang H; Meng G
    Trends Cancer; 2023 Oct; 9(10):855-870. PubMed ID: 37407363
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic variants, neurocognitive outcomes, and functional neuroimaging in survivors of childhood acute lymphoblastic leukemia.
    Gandy K; Sapkota Y; Scoggins MA; Jacola LM; Koscik TR; Hudson MM; Pui CH; Krull KR; van der Plas E
    JNCI Cancer Spectr; 2023 Jul; 7(4):. PubMed ID: 37285328
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung cancer in Sweden.
    Naik J; Beavers N; Nilsson FOL; Iadeluca L; Lowry C
    Appl Health Econ Health Policy; 2023 Jul; 21(4):661-672. PubMed ID: 37173513
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.
    Tesileanu CMS; Michaleas S; Gonzalo Ruiz R; Mariz S; Fabriek BO; van Hennik PB; Dedorath J; Dekic B; Unkrig C; Brandt A; Koenig J; Enzmann H; Delgado J; Pignatti F
    Oncologist; 2023 Jul; 28(7):628-632. PubMed ID: 37141403
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 37.